Mark Rosenblum

2.9k total citations · 1 hit paper
17 papers, 1.8k citations indexed

About

Mark Rosenblum is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Neurology. According to data from OpenAlex, Mark Rosenblum has authored 17 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 5 papers in Neurology. Recurrent topics in Mark Rosenblum's work include Glioma Diagnosis and Treatment (5 papers), Autoimmune Neurological Disorders and Treatments (3 papers) and Prostate Cancer Treatment and Research (3 papers). Mark Rosenblum is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Autoimmune Neurological Disorders and Treatments (3 papers) and Prostate Cancer Treatment and Research (3 papers). Mark Rosenblum collaborates with scholars based in United States, Chile and India. Mark Rosenblum's co-authors include Jerome B. Posner, Francesc Graus, Josep Dalmau, Ali Ziada, E. David Crawford, E. David Crawford, Tom Mikkelsen, Mary Ellen Steed, Yuri Kotliarov and Howard A. Fine and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer Research.

In The Last Decade

Mark Rosenblum

17 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients

1992 609 citations Josep Dalmau, Francesc Graus et al. Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Rosenblum United States	13	757	504	474	387	285	17	1.8k
Maria Michiara Italy	21	277 0.4×	378 0.8×	345 0.7×	178 0.5×	618 2.2×	81	1.6k
Cristina Carrato Spain	20	304 0.4×	211 0.4×	612 1.3×	185 0.5×	319 1.1×	64	1.5k
Tsugio Seki United States	26	161 0.2×	370 0.7×	1.3k 2.7×	386 1.0×	188 0.7×	41	2.4k
Lauri Miller United States	12	111 0.1×	348 0.7×	998 2.1×	44 0.1×	444 1.6×	16	2.1k
Karin Forsberg Sweden	22	942 1.2×	103 0.2×	774 1.6×	563 1.5×	273 1.0×	44	1.8k
Suash Sharma United States	21	306 0.4×	307 0.6×	622 1.3×	306 0.8×	245 0.9×	68	1.8k
Casilda Balmaceda United States	26	719 0.9×	431 0.9×	396 0.8×	947 2.4×	846 3.0×	51	2.4k
Alexandre Chlenski United States	28	465 0.6×	194 0.4×	1.1k 2.3×	67 0.2×	345 1.2×	44	1.8k
Federica Pisati Italy	28	123 0.2×	148 0.3×	1.5k 3.2×	674 1.7×	516 1.8×	55	2.4k
Fabio Rotondo Canada	29	160 0.2×	392 0.8×	893 1.9×	754 1.9×	318 1.1×	108	2.6k

Countries citing papers authored by Mark Rosenblum

Since Specialization

Citations

This map shows the geographic impact of Mark Rosenblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rosenblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rosenblum more than expected).

Fields of papers citing papers by Mark Rosenblum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rosenblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rosenblum. The network helps show where Mark Rosenblum may publish in the future.

Co-authorship network of co-authors of Mark Rosenblum

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Rosenblum. A scholar is included among the top collaborators of Mark Rosenblum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Rosenblum. Mark Rosenblum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rosenblum, Mark, et al.. (2011). Paraneoplastic cerebellar degeneration: I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 77(18). 1690–1690. 19 indexed citations

Torcuator, Roy, Mehul Patel, Joseph Anderson, et al.. (2009). The role of salvage reirradiation for malignant gliomas that progress on bevacizumab. Journal of Neuro-Oncology. 97(3). 401–407. 36 indexed citations

Li, Aiguo, Jennifer Walling, Yuri Kotliarov, et al.. (2008). Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas. Molecular Cancer Research. 6(1). 21–30. 195 indexed citations

Kotliarov, Yuri, Mary Ellen Steed, Neil Christopher, et al.. (2006). High-resolution Global Genomic Survey of 178 Gliomas Reveals Novel Regions of Copy Number Alteration and Allelic Imbalances. Cancer Research. 66(19). 9428–9436. 92 indexed citations

Fangusaro, Jason, Rima Jubran, Jeffrey C. Allen, et al.. (2006). Brainstem primitive neuroectodermal tumors (bstPNET): Results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue. Pediatric Blood & Cancer. 50(3). 715–717. 16 indexed citations

Ziada, Ali, Albaha Barqawi, L. Michael Glode, et al.. (2004). The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. The Prostate. 60(4). 332–337. 141 indexed citations

Morlock, Robert, et al.. (2002). Expectations, Outcomes, and Medical Costs in Patients with Low Back Pain Referred to Physical Therapy. Disease Management. 5(4). 185–188. 4 indexed citations

Bögler, Oliver, Susan Finniss, Sandra A. Rempel, et al.. (2001). Studying the heterogeneity of brain tumors using medium throughput LOH analysis. Cytometry. 47(1). 52–55. 4 indexed citations

Croteau, David, Tom Mikkelsen, Sandra A. Rempel, Oliver Bögler, & Mark Rosenblum. (2001). New innovations and developments for glioma treatment.. PubMed. 48. 60–81. 4 indexed citations

10.

Crawford, E. David, Mark Rosenblum, Ali Ziada, & Paul H. Lange. (1999). Overview: hormone refractory prostate cancer. Urology. 54(6). 1–7. 84 indexed citations

11.

Ziada, Ali, et al.. (1999). ANDROGEN DEPRIVATION THERAPY USING FINASTERIDE AND LOW DOSE FLUTAMIDE TO TREAT PSA FAILURE FOLLOWING THERAPY FOR CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATE (CaP). The Journal of Urology. 299–299. 14 indexed citations

12.

Ziada, Ali, Mark Rosenblum, & E. David Crawford. (1999). Benign prostatic hyperplasia: an overview. Urology. 53(3). 1–6. 337 indexed citations

13.

Mason, Warren, Alfred Grovas, Samantha E. Halpern, et al.. (1998). Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.. Journal of Clinical Oncology. 16(1). 210–221. 180 indexed citations

14.

Dalmau, Josep, Francesc Graus, Mark Rosenblum, & Jerome B. Posner. (1992). Anti-Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients. Medicine. 71(2). 59–72. 609 indexed citations breakdown →

15.

Kim, Jae Ho, et al.. (1990). Low dose rate radiotherapy for transplantable gliosarcoma in the rat brain. Journal of Neuro-Oncology. 9(1). 9–15. 8 indexed citations

16.

Wallner, Kent E., Joseph H. Galicich, Mark G. Malkin, et al.. (1989). Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation.. Journal of Clinical Oncology. 7(10). 1492–1496. 29 indexed citations

17.

Anderson, Neil E., Mark Rosenblum, Francesc Graus, et al.. (1988). An antineuronal autoantibody in paraneoplastic opsoclonus. Annals of Neurology. 23(5). 528–531. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact